Cargando…
Detection of circulating natural antibodies against CD25, MUC1, and VEGFR1 for early diagnosis of non‐small cell lung cancer
We previously demonstrated that a deficiency of natural antibodies against CD25, Mucin 1 (MUC1), and vascular endothelial growth factor receptor 1 (VEGFR1) could contribute to high risk of non‐small cell lung cancer (NSCLC). This study was designed to investigate whether natural IgG antibodies again...
Autores principales: | Liu, Siqi, Zhang, Xuan, Jiang, Quanhang, Liang, Tingting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327917/ https://www.ncbi.nlm.nih.gov/pubmed/32392378 http://dx.doi.org/10.1002/2211-5463.12878 |
Ejemplares similares
-
Altered levels of circulating natural antibodies against
VEGFR1-derived peptide in atherosclerosis
por: Wang, Peng, et al.
Publicado: (2020) -
Further analysis of natural antibodies against ischemic stroke
por: Qi, Jingjing, et al.
Publicado: (2023) -
Suppression of MUC1-Overexpressing Tumors by a Novel MUC1/CD3 Bispecific Antibody
por: Fang, Jun, et al.
Publicado: (2023) -
Circulating CD133(+)VEGFR2(+) and CD34(+)VEGFR2(+) cells and arterial function in patients with beta-thalassaemia major
por: Cheung, Yiu-fai, et al.
Publicado: (2011) -
CD144, CD146 and VEGFR-2 properly identify circulating endothelial cell
por: Flores-Nascimento, Mariane Cristina, et al.
Publicado: (2015)